SCHEMBL7860747

SCHEMBL7860747

Fc1cc(F)cc(B2OB(c3cc(F)cc(F)c3)OB(c3cc(F)cc(F)c3)O2)c1

nearest known ligand 0.38

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.38
CES1 P23141 1/20 0.38
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA9 Q16790 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16162375 0.74 CES2 (0.35) CES2CES1CA1
SCHEMBL7858647 0.74 CES2 (0.41) CES2CES1
SCHEMBL9948194 0.72 LPL (0.57) CA12CA1CA9
SCHEMBL14227215 0.72 CES2 (0.31) CES2CES1
SCHEMBL6829603 0.72 CES2 (0.31) CES2CES1
SCHEMBL14227196 0.71 CYP19A1 (0.33) CES2CES1
SCHEMBL14227208 0.71 CES2 (0.30) CES2CES1
SCHEMBL1484225 0.69 LPL (0.32) CA12CA1CA9
SCHEMBL12077787 0.69 CES2 (0.31) CES2CES1
SCHEMBL449836 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110891958-B Lithium borofluorophosphate complex, composition containing lithium borofluorophosphate, nonaqueous electrolyte for battery, and lithium secondary battery 三井化学株式会社 2023-07-11 CN disclosed
US-11597736-B2 Lithium boron fluorophosphate complex compound, lithium boron fluorophosphate-containing composition, lithium boron fluorophosphate, additive for lithium secondary battery, non-aqueous electrolytic solution for battery, and lithium secondary battery MITSUI CHEMICALS, INC. (JP) 2023-03-07 US disclosed
EP-0736509-B1 Processes for preparing optically active alcohols and optically active amines SUMITOMO CHEMICAL CO (JP) 2001-11-14 EP disclosed
US-6025531-A REACTING A PROCHIRAL KETONE WITH A MIXTURE BORON-CONTAINING COMPOUNDS HAVING A BORANE REACTION PRODUCT FROM OPTICALLY ACTIVE BETA-AMINOALCOHOL AND A BORON HYDRIDE OR A METAL BOROHYDRIDE, AND AN OPTICALLY ACTIVE OXAZABOROLIDINE SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2000-02-15 US disclosed
US-5801280-A Processes for preparing optically active alcohols and optically active amines SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1998-09-01 US disclosed
EP-0736509-A2 Processes for preparing optically active alcohols and optically active amines SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1996-10-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11597736-B2 Lithium boron fluorophosphate complex compound, lithium boron fluorophosphate-containing composition, lithium boron fluorophosphate, additive for lithium secondary battery, non-aqueous electrolytic solution for battery, and lithium secondary battery F9, BCL9L, SLC9B2 CES2 1445/4885CES1 3897/4885CA12 182/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.